Voyager Therapeutics, Inc. (VYGR)
2.18
-0.09
(-3.96%)
USD |
NASDAQ |
Oct 13, 15:46
Voyager Therapeutics Profit Margin (Quarterly) : -773.2% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -773.2% |
| March 31, 2026 | -1.08K% |
| December 31, 2025 | -178.8% |
| September 30, 2025 | -208.7% |
| June 30, 2025 | -642.0% |
| March 31, 2025 | -479.2% |
| December 31, 2024 | -549.3% |
| September 30, 2024 | -36.72% |
| June 30, 2024 | -34.29% |
| March 31, 2024 | -58.05% |
| December 31, 2023 | 62.62% |
| September 30, 2023 | -561.4% |
| June 30, 2023 | -457.6% |
| March 31, 2023 | 82.43% |
| December 31, 2022 | |
| September 30, 2022 | 42.90% |
| June 30, 2022 | -2.68K% |
| March 31, 2022 | -3.24K% |
| December 31, 2021 | 20.34% |
| September 30, 2021 | -1.70K% |
| June 30, 2021 | -2.22K% |
| March 31, 2021 | -333.0% |
| December 31, 2020 | -243.6% |
| Date | Value |
|---|---|
| September 30, 2020 | 72.65% |
| June 30, 2020 | -30.27% |
| March 31, 2020 | -134.3% |
| December 31, 2019 | -38.49% |
| September 30, 2019 | -73.44% |
| June 30, 2019 | 24.20% |
| March 31, 2019 | -522.8% |
| December 31, 2018 | -1.12K% |
| September 30, 2018 | -968.9% |
| June 30, 2018 | -991.9% |
| March 31, 2018 | -2.12K% |
| December 31, 2017 | -185.5% |
| September 30, 2017 | -2.03K% |
| June 30, 2017 | -1.60K% |
| March 31, 2017 | -1.14K% |
| December 31, 2016 | -621.2% |
| September 30, 2016 | -271.9% |
| June 30, 2016 | -250.9% |
| March 31, 2016 | -148.8% |
| December 31, 2015 | -147.5% |
| September 30, 2015 | -79.34% |
| June 30, 2015 | -79.75% |
| March 31, 2015 | -565.9% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | -1.64% |
| Amgen, Inc. | 23.59% |
| Anika Therapeutics, Inc. | 10.15% |
| BioCryst Pharmaceuticals, Inc. | 35.92% |
| Imunon, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -54.52% |
| Return on Assets | -42.09% |
| Return on Invested Capital | -46.03% |
| Gross Profit Margin (Quarterly) | 71.31% |
| Operating Margin (Quarterly) | -833.9% |
| Return on Net Operating Assets | -246.9% |